Do we still need broad patient representation in breast cancer trials? Absolutely.
Related Insights
Article
Navigating the challenges of large, international Phase III breast cancer trials
Jul 29, 2025
Blog
Patient-guided oncology trials: Why the patient perspective is essential to success
Jun 4, 2024
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
Highlights from ASCO: Our experts weigh in
Jul 13, 2021
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
Blog
The Next Frontier of ADC Development: Navigating an Evolving Regulatory Landscape
Aug 12, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
Blog
FDA novel oncology drug approvals in 2025: Trends and strategic insights for developers
Mar 31, 2026
Playbook
Advancing radiopharmaceutical development: A playbook for integrated clinical trial delivery
Mar 11, 2026
Playbook
Preparing clinical infrastructure for radiopharmaceutical trials
Mar 11, 2026
Related Insights
Article
Navigating the challenges of large, international Phase III breast cancer trials
Jul 29, 2025
Blog
Patient-guided oncology trials: Why the patient perspective is essential to success
Jun 4, 2024
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
Highlights from ASCO: Our experts weigh in
Jul 13, 2021
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
Blog
The Next Frontier of ADC Development: Navigating an Evolving Regulatory Landscape
Aug 12, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
Blog
FDA novel oncology drug approvals in 2025: Trends and strategic insights for developers
Mar 31, 2026
Playbook
Advancing radiopharmaceutical development: A playbook for integrated clinical trial delivery
Mar 11, 2026
Playbook
Preparing clinical infrastructure for radiopharmaceutical trials
Mar 11, 2026